Quantitative Analysis of the Impact of Total Ischemic Time on Myocardial Perfusion and Clinical Outcome in Patients With ST-Elevation Myocardial Infarction

被引:23
作者
Fokkema, Marieke L. [1 ]
Wieringa, Wouter G. [1 ]
van der Horst, Iwan C. [1 ]
Boersma, Eric [2 ]
Zijlstra, Felix [2 ]
de Smet, Bart J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Thoraxctr, Dept Cardiol, Groningen, Netherlands
[2] Erasmus MC, Thoraxctr, Dept Clin Epidemiol, Rotterdam, Netherlands
关键词
PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; REPERFUSION; CLOPIDOGREL; ABCIXIMAB; SIZE; METAANALYSIS; MORTALITY; OCCLUSION; THROMBUS;
D O I
10.1016/j.amjcard.2011.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early reperfusion of the infarct-related coronary artery is an important issue in improvement of outcomes after ST-segment elevation myocardial infarction (STEM!). In this study, the clinical significance of total ischemic time on myocardial reperfusion and clinical outcomes was evaluated in patients with STEMI treated with primary percutaneous coronary intervention and thrombus aspiration and additional triple-antiplatelet therapy. Total ischemic time was defined as time from symptom onset to first intracoronary therapy (first balloon inflation or thrombus aspiration). All patients with STEMI treated with primary percutaneous coronary intervention with total ischemic times >= 30 minutes and <24 hours from 2005 to 2008 were selected. Ischemic times were available in 1,383 patients, of whom 18.4% presented with total ischemic times <= 2 hours, 31.2% >2 to 3 hours, 26.8% >3 to 5 hours, and 23.5% >5 hours. Increased ischemic time was associated with age, female gender, hypertension, and diabetes. Patients with total ischemic times <5 hours more often had myocardial blush grade 3 (40% to 45% vs 22%, p <0.001) and complete ST-segment resolution (55% to 60% vs 42%, p = 0.002) than their counterparts with total ischemic times >5 hours. In addition, patients with total ischemic times <= 5 hours had lower 30-day mortality (1.5% vs 4.0%, p = 0.032) than patients with total ischemic times >5 hours. In conclusion, in this contemporary cohort of patients with STEMI treated with primary percutaneous coronary intervention, triple-antiplatelet therapy, and thrombus aspiration, short ischemic time was associated with better myocardial reperfusion and decreased mortality. After a 5-hour period in which outcomes remain relatively stable, myocardial reperfusion becomes suboptimal and mortality increases. (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;108:1536-1541)
引用
收藏
页码:1536 / 1541
页数:6
相关论文
共 29 条
  • [21] Bivalirudin during primary PCI in acute myocardial infarction
    Stone, Gregg W.
    Witzenbichler, Bernhard
    Guagliumi, Giulio
    Peruga, Jan Z.
    Brodie, Bruce R.
    Dudek, Dariusz
    Kornowski, Ran
    Hartmann, Franz
    Gersh, Bernard J.
    Pocock, Stuart J.
    Dangas, George
    Wong, S. Chiu
    Kirtane, Ajay J.
    Parise, Helen
    Mehran, Roxana
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (21) : 2218 - 2230
  • [22] Thrombus aspiration during primary percutaneous coronary intervention
    Svilaas, Tone
    Vlaar, Pieter J.
    van der Horst, Iwan C.
    Diercks, Gilles F. H.
    de Smet, Bart J. G. L.
    van den Heuvel, Ad F. M.
    Anthonio, Rutger L.
    Jessurun, Gillian A.
    Tan, Eng-Shiong
    Suurmeijer, Albert J. H.
    Zijlstra, Felix
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) : 557 - 567
  • [23] Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty - A study performed with contrast-enhanced magnetic resonance
    Tarantini, G
    Cacciavillani, L
    Corbetti, F
    Ramondo, A
    Marra, MP
    Bacchiega, E
    Napodano, M
    Bilato, C
    Razzolini, R
    Iliceto, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (07) : 1229 - 1235
  • [24] Thygesen K, 2007, EUR HEART J, V28, P2525
  • [25] Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction - Myocardial blush grade
    van't Hof, AWJ
    Liem, A
    Suryapranata, H
    Hoorntje, JCA
    de Boer, MJ
    Zijlstra, F
    [J]. CIRCULATION, 1998, 97 (23) : 2302 - 2306
  • [26] Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
    vantHof, AWJ
    Liem, A
    deBoer, MJ
    Zijlstra, F
    [J]. LANCET, 1997, 350 (9078) : 615 - 619
  • [27] Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction A Systematic Review
    Vlaar, Pieter J.
    Svilaas, Tone
    Damman, Kevin
    de Smet, Bart J. G. L.
    Tijssen, Jan G. P.
    Hillege, Hans L.
    Zijlstra, Felix
    [J]. CIRCULATION, 2008, 118 (18) : 1828 - 1836
  • [28] Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
    Wallentin, Lars
    Becker, Richard C.
    Budaj, Andrzej
    Cannon, Christopher P.
    Emanuelsson, Hakan
    Held, Claes
    Horrow, Jay
    Husted, Steen
    James, Stefan
    Katus, Hugo
    Mahaffey, Kenneth W.
    Scirica, Benjamin M.
    Skene, Allan
    Steg, Philippe Gabriel
    Storey, Robert F.
    Harrington, Robert A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11) : 1045 - 1057
  • [29] Randomized Comparison of Eptifibatide Versus Abciximab in Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction Results of the EVA-AMI Trial
    Zeymer, Uwe
    Margenet, Alain
    Haude, Michael
    Bode, Christoph
    Lablanche, Jean-Marc
    Heuer, Hubertus
    Schroeder, Rolf
    Kropff, Stefan
    Bourkaib, Ryad
    Banik, Norbert
    Zahn, Ralf
    Teiger, Emmanuel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (06) : 463 - 469